Ciprofloxacin (Cipro) is a second-generation fluoroquinolone antibiotic effective against gram-negative bacteria, used for UTIs, pyelonephritis, respiratory infections, bone infections, and inhalational anthrax. It works by inhibiting bacterial DNA gyrase and topoisomerase IV, causing DNA strand breaks and rapid bactericidal activity. Common side effects include nausea, diarrhea, headache, and photosensitivity. It carries FDA boxed warnings for tendinitis and tendon rupture, peripheral neuropathy, CNS effects, and myasthenia gravis exacerbation; concurrent intake with dairy, antacids, or iron can reduce absorption by up to 90%.
Ciprofloxacin
Uses & FDA Indications
Ciprofloxacin is a second-generation fluoroquinolone with a broad spectrum of antibacterial activity, particularly against gram-negative organisms. It is one of the most commonly prescribed antibiotics in the United States, though concerns about resistance and serious adverse effects have led guidelines to recommend reserving it for infections where alternatives are inadequate.
FDA-approved indications span multiple organ systems and include urinary tract infections (including complicated UTIs and pyelonephritis), lower respiratory tract infections, skin and soft tissue infections, bone and joint infections, infectious diarrhea, intra-abdominal infections (with metronidazole), typhoid fever, urethral and cervical gonorrhea (no longer recommended due to resistance), and inhalational anthrax (post-exposure prophylaxis). The extended-release tablet (Cipro XR) is specifically indicated for uncomplicated and complicated UTIs.
- Urinary tract infections (UTI, pyelonephritis)
- Lower respiratory tract infections (including chronic bronchitis exacerbations)
- Skin and soft tissue infections
- Bone and joint infections (osteomyelitis)
- Infectious diarrhea caused by E. coli, Campylobacter, Shigella
- Intra-abdominal infections (with metronidazole)
- Typhoid fever (enteric fever)
- Inhalational anthrax (post-exposure prophylaxis and treatment)
- Nosocomial pneumonia (in combination)
- Plague and tularemia (bioterrorism agents)
How It Works
Ciprofloxacin inhibits two essential bacterial enzymes involved in DNA replication and repair: DNA gyrase (topoisomerase II) and topoisomerase IV. Both enzymes are required to manage the supercoiling of bacterial DNA — without their activity, DNA cannot be properly replicated or transcribed, leading to double-strand DNA breaks and rapid bacterial cell death. This mechanism makes ciprofloxacin concentration-dependent and bactericidal.
Ciprofloxacin is particularly active against aerobic gram-negative bacilli — including Escherichia coli, Klebsiella, Enterobacter, Pseudomonas aeruginosa, Haemophilus influenzae, Neisseria, Salmonella, Shigella, and Campylobacter. Its activity against gram-positive organisms and anaerobes is limited compared to newer fluoroquinolones like levofloxacin or moxifloxacin.
Ciprofloxacin carries an FDA Boxed Warning for serious adverse effects including tendinitis, tendon rupture, peripheral neuropathy, and central nervous system effects. These risks have prompted guidelines to recommend reserving fluoroquinolones for infections with no safe and effective alternatives.
Side Effects
Common
- Nausea, diarrhea, vomiting, abdominal discomfort
- Headache and dizziness
- Rash
- Insomnia
- Elevated liver enzymes (transaminases)
- Photosensitivity — increased susceptibility to sunburn
- Taste disturbance
Serious
- Tendinitis and tendon rupture — Achilles tendon most common; risk elevated in older adults, corticosteroid users, and those with renal, heart, or lung transplants (Boxed Warning)
- Peripheral neuropathy — potentially irreversible sensory or sensorimotor axonal polyneuropathy (Boxed Warning)
- CNS effects — seizures, toxic psychosis, tremors, anxiety, depression, confusion, hallucinations (Boxed Warning)
- Aortic aneurysm and dissection — rare but potentially fatal; risk higher in elderly patients
- QT interval prolongation and cardiac arrhythmias (torsades de pointes)
- Clostridioides difficile-associated diarrhea and colitis
- Severe hypersensitivity reactions including anaphylaxis and Stevens-Johnson syndrome
- Blood glucose disturbances — both hypoglycemia and hyperglycemia reported
- Exacerbation of myasthenia gravis (Boxed Warning)
Drug Interactions
| Drug / Class | Interaction | Clinical Significance |
|---|---|---|
| Antacids (aluminum/magnesium), calcium supplements, iron, zinc, sucralfate, dairy products | Chelate ciprofloxacin in the GI tract, dramatically reducing absorption (up to 90% reduction) | High — take ciprofloxacin 2 hours before or 6 hours after these agents |
| Theophylline and methylxanthines | Ciprofloxacin inhibits CYP1A2, markedly increasing theophylline levels; risk of theophylline toxicity (seizures, arrhythmias) | High — monitor theophylline levels closely; consider dose reduction |
| Warfarin | Ciprofloxacin inhibits CYP1A2 and displaces warfarin; INR can rise significantly | High — monitor INR frequently during and after ciprofloxacin course |
| QT-prolonging agents (antiarrhythmics, antipsychotics, tricyclics, ondansetron) | Additive QT prolongation; risk of torsades de pointes | High — avoid combination or monitor ECG closely |
| Antidiabetic agents (sulfonylureas, insulin) | Fluoroquinolones can cause both hypoglycemia and hyperglycemia; may enhance hypoglycemic effects | Moderate — monitor blood glucose carefully in diabetic patients |
| Clozapine and ropinirole | Ciprofloxacin inhibits CYP1A2, raising levels of both drugs and increasing toxicity risk | Moderate–High — monitor levels; may require dose adjustment |
| NSAIDs (ibuprofen, naproxen) | Combination may lower seizure threshold; additive CNS stimulant effect | Moderate — avoid in patients with seizure history |
Warnings & Contraindications
⚠ BOXED WARNINGS: (1) Tendinitis and tendon rupture — stop immediately and avoid physical activity if tendon pain develops. (2) Peripheral neuropathy — potentially irreversible. (3) CNS effects including seizures. (4) Exacerbation of myasthenia gravis — potentially life-threatening respiratory failure. Fluoroquinolones should be reserved for infections without safe alternatives.
- Contraindicated: Hypersensitivity to ciprofloxacin or other fluoroquinolones; concurrent use with tizanidine (ciprofloxacin dramatically raises tizanidine levels, causing severe hypotension and sedation)
- Aortic aneurysm: FDA (2018) added warning — patients with known aortic aneurysm or at risk (Marfan syndrome, elderly, hypertension) should avoid fluoroquinolones unless no alternatives exist
- Pediatric use: Generally avoided in children due to risk of arthropathy (joint damage) observed in juvenile animal studies; FDA-approved for certain serious infections (anthrax, complicated UTI) where benefit outweighs risk
- Renal impairment: Ciprofloxacin is renally eliminated; dose adjustment required in severe renal impairment to avoid drug accumulation and CNS toxicity
- Pregnancy: Category C — should be avoided when alternatives exist; limited human data, but animal studies suggest possible fetal joint effects
- Resistance stewardship: Increasing resistance among E. coli and other organisms has made empiric use for UTIs less reliable in many regions; culture and sensitivity results should guide therapy
Frequently Asked Questions
Why can't I take ciprofloxacin with dairy or antacids?
Ciprofloxacin is a chelating molecule that binds tightly to divalent and trivalent cations — including calcium (in dairy and calcium supplements), magnesium and aluminum (in antacids), iron, and zinc. When these complexes form in the gastrointestinal tract, they are too large to be absorbed, and the drug passes through without entering the bloodstream. Studies show that concurrent intake can reduce ciprofloxacin bioavailability by 50–90%. The solution is to take ciprofloxacin at least 2 hours before or 6 hours after these products.
Is ciprofloxacin still a good antibiotic for UTIs?
Ciprofloxacin was historically a go-to antibiotic for UTIs, but resistance rates among uropathogens — especially E. coli — have risen significantly in many communities. Current IDSA guidelines recommend reserving fluoroquinolones for complicated UTIs, pyelonephritis, or situations where other agents (nitrofurantoin, trimethoprim-sulfamethoxazole, fosfomycin) are not appropriate. Using ciprofloxacin for simple, uncomplicated UTIs when alternatives work is discouraged to preserve its efficacy for more serious infections and reduce collateral resistance development.
What should I do if my Achilles tendon starts hurting while on ciprofloxacin?
Stop physical activity, contact your healthcare provider, and do not continue ciprofloxacin without medical reassessment. Tendinitis and tendon rupture are recognized adverse effects of fluoroquinolones — the Achilles tendon is most commonly affected. Risk is highest in patients over 60, those taking corticosteroids concurrently, and organ transplant recipients. If tendon rupture occurs, it can require surgery and prolonged rehabilitation. The provider may switch you to a different antibiotic class.
Can ciprofloxacin affect my mental health?
Yes. Fluoroquinolones including ciprofloxacin can cause CNS adverse effects including anxiety, agitation, insomnia, restlessness, confusion, depression, and — rarely — hallucinations or psychosis. These effects may occur even after the first dose. Patients with a history of seizures, CNS disorders, or psychiatric conditions are at higher risk. If you experience unusual mood changes, confusion, or neurological symptoms during treatment, contact your healthcare provider immediately. These effects generally resolve after stopping the medication.
Not sure which pill you have? Identify it by imprint, color, or shape.
Use the PillID Identifier →